4,5,6,7-tetrabromo-2-azabenzimidazole has been researched along with Lymphoma, Large-Cell, Anaplastic in 1 studies
4,5,6,7-tetrabromobenzotriazole: a CK2 kinase inhibitor
Lymphoma, Large-Cell, Anaplastic: A systemic, large-cell, non-Hodgkin, malignant lymphoma characterized by cells with pleomorphic appearance and expressing the CD30 ANTIGEN. These so-called hallmark cells have lobulated and indented nuclei. This lymphoma is often mistaken for metastatic carcinoma and MALIGNANT HISTIOCYTOSIS.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Armanious, H | 1 |
| Gelebart, P | 1 |
| Anand, M | 1 |
| Lai, R | 1 |
1 other study available for 4,5,6,7-tetrabromo-2-azabenzimidazole and Lymphoma, Large-Cell, Anaplastic
| Article | Year |
|---|---|
Identification of a novel crosstalk between casein kinase 2α and NPM-ALK in ALK-positive anaplastic large cell lymphoma.
Topics: beta Catenin; Casein Kinase II; Cell Communication; Cell Line, Tumor; Cell Proliferation; Cell Trans | 2013 |